Innovation in life sciences is crucial for many key industries in the United States and across the globe. It supports advances in human biotechnology, pharmaceuticals, health care policy, and beyond. Such advances would not always have been possible without the Bayh-Dole Act. Rob and Jackie sat down with Joe Allen, who served as a professional staffer on the U.S. Senate Judiciary Committee to former Senator Birch Bayh, to discuss the importance of the Bayh-Dole Act and the future of life sciences innovation. 

Related

• Stephen Ezell, “The Bayh-Dole Act’s Vital Importance to the U.S. Life-Sciences Innovation System” (ITIF, March 2019).
•  “Preserving Bayh-Dole—the “Inspired” Law That Underpins U.S. Leadership in Life-Sciences Innovation” (ITIF Event, March 2019).
• Stephen Ezell, “How Japan Squandered Its Biopharmaceutical Competitiveness: A Cautionary Tale” (ITIF, July 2022).